Search - tctmd.com

Displaying 141 - 160 of 242

Sort: Relevancy | Date

Presentation TCT 2016

TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in Coronary Flow Reserve the RESOLVING DISCORD Study

Presenter: Michalis Hamilos, Pim A.L. Tonino

October 30, 2016

Presentation

Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital

Presenter: H. Khalili

December 09, 2015

Presentation TCT 2015

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel

October 15, 2015

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Ricardo Sanz-Ruiz

October 15, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? With Micro and Nanotechnology in Cardiovascular Tissue Engineering!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Kevin E Healy

October 15, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? But Power Is Nothing Without Control Electromechanical Engraftment!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 15, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Doris A. Taylor

October 15, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Bioartificial Matrices, Which Are Available and Versatile!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Felipe Prosper

October 15, 2015

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse

October 15, 2015

Presentation TCT 2015

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo

October 15, 2015

Presentation TCT 2015

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Presenter: Steven R. Bailey, Patrick W. Serruys, Federico De Marco

October 15, 2015

Advertisement

TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in Coronary Flow Reserve the RESOLVING DISCORD Study

Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital

First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? With Micro and Nanotechnology in Cardiovascular Tissue Engineering!

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? But Power Is Nothing Without Control Electromechanical Engraftment!

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Bioartificial Matrices, Which Are Available and Versatile!

Stem CellBased Ablation for Ventricular Arrhythmias

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content